HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Hayashi Selected Research

gamma-Butyrobetaine Dioxygenase

11/2000Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts.
6/2000MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.
5/2000Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Hayashi Research Topics

Disease

55Neoplasms (Cancer)
03/2021 - 01/2000
10Leukemia
02/2015 - 01/2000
10Neuroblastoma
11/2012 - 03/2000
9Carcinogenesis
07/2014 - 01/2000
8Infections
10/2015 - 05/2000
8Hepatocellular Carcinoma (Hepatoma)
12/2001 - 04/2000
7Renal Cell Carcinoma (Grawitz Tumor)
01/2005 - 02/2000
6Fibrosis (Cirrhosis)
01/2016 - 01/2000
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2015 - 03/2000
6Carcinoma (Carcinomatosis)
06/2009 - 09/2000
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2008 - 03/2000
5Glioblastoma (Glioblastoma Multiforme)
04/2013 - 11/2000
5Neoplasm Metastasis (Metastasis)
09/2012 - 04/2000
5Heart Failure
01/2001 - 05/2000
4Adenocarcinoma
11/2016 - 01/2001
4Adenoma (Adenomas)
07/2014 - 02/2000
4Hemorrhage
04/2013 - 08/2001
4Ischemia
09/2006 - 11/2000
4Chronic Hepatitis (Chronic Active Hepatitis)
09/2001 - 05/2000
4Myocardial Infarction
03/2001 - 05/2000
4Spasm (Spasms)
01/2001 - 02/2000
3Disease Progression
12/2018 - 01/2001
3Breast Neoplasms (Breast Cancer)
08/2015 - 04/2001
3Lymphoma (Lymphomas)
02/2015 - 05/2010
3Alzheimer Disease (Alzheimer's Disease)
01/2015 - 01/2001
3Glioma (Gliomas)
06/2013 - 11/2000
3Type 2 Diabetes Mellitus (MODY)
06/2013 - 02/2000
3Chronic Hepatitis C
01/2005 - 01/2001
3Coronary Vasospasm (Coronary Artery Vasospasm)
11/2001 - 01/2001
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2001 - 05/2000
2Mouth Neoplasms (Oral Cancer)
10/2022 - 04/2001
2Encephalitis (Encephalitis, Rasmussen)
10/2020 - 01/2007
2Schizophrenia (Dementia Praecox)
01/2017 - 12/2012
2Obesity
01/2017 - 06/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2015 - 09/2012
2Central Nervous System Diseases (CNS Diseases)
02/2015 - 02/2010
2Brain Death (Brain Dead)
05/2014 - 06/2000
2Insulin Resistance
06/2013 - 01/2003
2Lung Neoplasms (Lung Cancer)
11/2012 - 09/2012
2Pneumonia (Pneumonitis)
07/2012 - 08/2001
2Meningioma (Meningiomas)
02/2012 - 01/2002
2Bone Resorption
08/2011 - 07/2000
2Blister (Bulla)
10/2009 - 06/2000
2Ventricular Fibrillation
07/2009 - 11/2000

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
08/2015 - 01/2000
14Messenger RNA (mRNA)IBA
03/2011 - 04/2000
8DNA (Deoxyribonucleic Acid)IBA
07/2014 - 06/2000
6Pharmaceutical PreparationsIBA
07/2017 - 05/2000
5fodrinIBA
06/2013 - 02/2001
5AntigensIBA
07/2012 - 03/2001
5EnzymesIBA
03/2011 - 04/2000
5Monoclonal AntibodiesIBA
10/2000 - 01/2000
4Prednisolone (Predate)FDA LinkGeneric
02/2015 - 08/2001
4Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2009 - 01/2000
4Capsules (Microcapsules)IBA
01/2005 - 06/2001
4Indicators and Reagents (Reagents)IBA
08/2004 - 02/2000
4Acetylcholine (Acetylcholine Chloride)FDA Link
09/2001 - 02/2000
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2001 - 09/2000
43-(2,2,2-trimethylhydrazine)propionateIBA
11/2000 - 05/2000
3SteroidsIBA
12/2018 - 01/2000
3CollagenIBA
01/2016 - 09/2000
3Fatty Acids (Saturated Fatty Acids)IBA
12/2012 - 07/2000
3AntibodiesIBA
04/2010 - 01/2000
3Superoxides (Superoxide)IBA
08/2005 - 01/2000
3InterferonsIBA
01/2005 - 01/2001
3beta CateninIBA
01/2002 - 04/2001
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2001 - 02/2000
3Peroxynitrous Acid (Peroxynitrite)IBA
08/2001 - 01/2000
3Codon (Codons)IBA
07/2001 - 04/2000
3Phenobarbital (Luminal)FDA Link
06/2001 - 06/2000
3AutoantigensIBA
05/2001 - 08/2000
3VimentinIBA
04/2001 - 01/2000
3CalciumIBA
01/2001 - 01/2000
3RNA (Ribonucleic Acid)IBA
01/2001 - 05/2000
3gamma-Butyrobetaine DioxygenaseIBA
11/2000 - 05/2000
2Glutamic Acid (Glutamate)FDA Link
01/2017 - 01/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2015 - 09/2000
2Analgesics (Analgesic Drugs)IBA
09/2014 - 03/2005
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2013 - 04/2001
2Oncogene Proteins (Oncogene Protein)IBA
03/2013 - 01/2000
2NucleophosminIBA
11/2012 - 06/2007
2Anti-Bacterial Agents (Antibiotics)IBA
07/2012 - 06/2011
2CateninsIBA
11/2011 - 01/2002
2Myosins (Myosin)IBA
07/2011 - 08/2000
2AutoantibodiesIBA
02/2010 - 01/2007
2Serotonin (5 Hydroxytryptamine)IBA
01/2010 - 12/2000
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2009 - 05/2000

Therapy/Procedure

28Therapeutics
10/2022 - 01/2000
9Drug Therapy (Chemotherapy)
10/2022 - 03/2000
5Transplantation
10/2015 - 07/2000
4Cardiopulmonary Bypass (Heart-Lung Bypass)
07/2001 - 05/2000
3Hematopoietic Stem Cell Transplantation
12/2018 - 02/2015
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2001 - 03/2001
3Ligation
02/2001 - 01/2000
3Aftercare (After-Treatment)
01/2001 - 05/2000
2Proton Therapy
10/2022 - 10/2015
2Conservative Treatment
04/2019 - 02/2002
2Organ Transplantation
05/2014 - 06/2000
2Operative Surgical Procedures
04/2013 - 01/2001
2Anesthesia
09/2012 - 01/2001